Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 18

1 Any per­son who stores health-re­lated per­son­al data in con­nec­tion with a clin­ic­al tri­al must take ap­pro­pri­ate op­er­a­tion­al and or­gan­isa­tion­al meas­ures to pro­tect it, and in par­tic­u­lar:

a.
re­strict the hand­ling of the health-re­lated per­son­al data to those per­sons who re­quire this data to ful­fil their du­ties;
b.
pre­vent un­au­thor­ised or ac­ci­dent­al dis­clos­ure, al­ter­a­tion, de­le­tion and copy­ing of the health-re­lated per­son­al data;
c.
doc­u­ment all pro­cessing op­er­a­tions which are es­sen­tial to en­sure trace­ab­il­ity.

2 Any per­son who stores bio­lo­gic­al ma­ter­i­al in con­nec­tion with a clin­ic­al tri­al must, in par­tic­u­lar:

a.
com­ply with the prin­ciples set out in para­graph 1 mu­tatis mutandis;
b.
en­sure that the tech­nic­al re­quire­ments are met for ap­pro­pri­ate stor­age of the bio­lo­gic­al ma­ter­i­al;
c.
make avail­able the re­sources re­quired for stor­age.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden